Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

June 17, 2025 updated by: Roswell Park Cancer Institute

Influence of Yoga on Cancer-Related Stress in Cancer Survivors

This clinical trial develops and test a yoga intervention in improving cancer-related stress in cancer survivors. The online hatha yoga intervention of breathing and movement incorporates both restorative poses, breathing techniques, guided meditation and may reduce stress levels and improve overall quality of health in cancer survivors.

Study Overview

Detailed Description

PRIMARY OBJECTIVE:

I. To develop and test the feasibility of a standardized 12-week online hatha yoga intervention (n=30) of breathing and movement incorporating both restorative poses, breathing techniques, guided meditation.

SECONDARY OBJECTIVES:

I. To evaluate the yoga intervention in relation to self-reported levels of stress and quality of life in cancer survivors (n=30).

II. Feasibility of collecting blood and saliva at baseline and post-intervention for stress biomarkers, including cortisol and norepinephrine.

EXPLORATORY OBJECTIVE:

I. To determine how behavior change, quality of life (QoL), and biomarkers of adrenergic stress, inflammation, and immunosuppression are affected by a 12-week online yoga program completed by cancer survivors.

OUTLINE:

Patients receive online yoga intervention once a week (QW) for 12 weeks.

After completion of study, patients are followed up at 3 months.

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Buffalo, New York, United States, 14263
        • Roswell Park Cancer Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age >= 18 years of age
  • Have been diagnosed with a cancer and have finished treatment
  • Have been cleared for physical activity by a physician or nurse practitioner (physician or nurse practitioner name and date clearance received)
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

  • Unwilling or unable to complete the assessment in English
  • Are pregnant or nursing
  • Are unwilling or unable to follow protocol requirements
  • Have skeletal instabilities and/or cardio-pulmonary comorbidities
  • Have any condition which in the investigator's opinion deems the subject an unsuitable candidate to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supportive care (yoga)
Patients receive online yoga intervention QW for 12 weeks.
Ancillary studies
Other Names:
  • Quality of Life Assessment
Ancillary studies
Receive yoga intervention
Other Names:
  • Yoga Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of subjects who participate or show high adherence to the intervention
Time Frame: Up to 12 weeks
Will be presented as observed proportion and 95% Clopper-Pearson confidence intervals (CIs).
Up to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of the intervention in stress-reduction
Time Frame: Up to 3 months post-intervention
Serum cortisol and norepinephrine levels will be measured by blood collection
Up to 3 months post-intervention
Efficacy of the intervention in stress-reduction
Time Frame: Up to 3 months post intervention
Self report stress
Up to 3 months post intervention
Efficacy of the intervention in stress reduction
Time Frame: Up to 3 months post intervention
salivary cortisol will be measured by saliva collection
Up to 3 months post intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Quality of life
Time Frame: Up to 3 months post-intervention
Quality of life collected by the EORTC Quality of Life Questionnaire
Up to 3 months post-intervention
Change in Cognitive function
Time Frame: Up to 12 weeks
Cognitive function will be assessed by standard questionnaires
Up to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathryn Glaser, Roswell Park Cancer Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2021

Primary Completion (Actual)

March 22, 2024

Study Completion (Actual)

June 18, 2024

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

February 11, 2021

First Posted (Actual)

February 15, 2021

Study Record Updates

Last Update Posted (Actual)

June 22, 2025

Last Update Submitted That Met QC Criteria

June 17, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • I 891720 (Other Identifier: Roswell Park Cancer Institute)
  • NCI-2021-00698 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hematopoietic and Lymphoid Cell Neoplasm

Clinical Trials on Quality-of-Life Assessment

Subscribe